EUROPACE, cilt.10, sa.2, ss.210-214, 2008 (SCI-Expanded)
Aims We aimed to clarify whether determination of levels of soluble CD40 ligand (sCD40L) could predict subsequent thrombo-embolic events in patients with non-valvular atrial fibrillation (NVAF).